Genetesis

Mason, United States

Genetesis is a medical imaging company leveraging data science and biomagnetism in the fight against cardiovascular disease

$17.5M raised

Oct 2022

Series C

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Genetesis raised?

Genetesis has raised $17.5M in total funding. The most recent round was Series C. The last funding was announced in October 2022.

Who are Genetesis's investors?

Genetesis's investors include TDK Ventures, Mithril Capital Management, CincyTech, JobsOhio, Raptor Group.

Where is Genetesis headquartered?

Genetesis is headquartered in Mason, United States.

What does Genetesis do?

Genetesis is a medical imaging company leveraging data science and biomagnetism in the fight against cardiovascular disease

What stage is Genetesis at?

Genetesis is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 6, 2022.

MLA

"Genetesis — Funding & Investors." VCBacked, October 6, 2022, https://www.vcbacked.co/company/genetesis. Accessed July 2, 2026.

APA

VCBacked. (2022). Genetesis — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/genetesis

Wikipedia (cite web)

{{cite web |title=Genetesis — Funding & Investors |url=https://www.vcbacked.co/company/genetesis |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 6, 2022.